Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
- Study type
- Clinical guideline
- Study name
- ESMO Early Breast Cancer 2024
- Design
- Clinical guideline (ESMO Clinical Practice Guideline), developed by the ESMO Guidelines Committee
- Source
- Annals of Oncology · 2024
In plain words
This article is the official guideline of the European Society for Medical Oncology (ESMO) for the diagnosis, treatment and follow-up of early breast cancer. Guidelines like this help doctors use the best evidence-based approaches for each patient. To find out which recommendations fit your own situation, talk to your treating doctor.
Study population
The PubMed record has no abstract. Based on its title, this guideline concerns early breast cancer. Details of the target population are given in the full text of the guideline.
Endpoints
Details are in the full text of the paper.
Safety and side effects
Details are in the full text of the paper.
Clinical significance and place in guidelines
This document is the ESMO clinical guideline for the diagnosis, treatment and follow-up of early breast cancer. The PubMed record has no abstract, so the specific recommendations and their levels of evidence must be extracted and checked from the full text of the guideline.
Limitations
The PubMed record has no abstract and contains no recommendations, levels of evidence or treatment details. This card should be completed after reading the full text of the guideline and review by an oncologist.
This summary was prepared by the editorial team from the published paper; the original paper is the final reference. Read the original abstract on PubMed.